These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19820803)

  • 41. Gene therapy to rescue retinal degeneration caused by mutations in rhodopsin.
    Rossmiller BP; Ryals RC; Lewin AS
    Methods Mol Biol; 2015; 1271():391-410. PubMed ID: 25697537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.
    Gu SM; Thompson DA; Srikumari CR; Lorenz B; Finckh U; Nicoletti A; Murthy KR; Rathmann M; Kumaramanickavel G; Denton MJ; Gal A
    Nat Genet; 1997 Oct; 17(2):194-7. PubMed ID: 9326941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotective gene therapy for the treatment of inherited retinal degeneration.
    Buch PK; MacLaren RE; Ali RR
    Curr Gene Ther; 2007 Dec; 7(6):434-45. PubMed ID: 18045103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease.
    Martinez Velazquez LA; Ballios BG
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene therapeutic approaches for dominant retinopathies.
    Farrar GJ; Palfi A; O'Reilly M
    Curr Gene Ther; 2010 Oct; 10(5):381-8. PubMed ID: 20712579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene therapy for retinal degeneration.
    Reichel MB; Ali RR; Hunt DM; Bhattacharya SS
    Ophthalmic Res; 1997; 29(5):261-8. PubMed ID: 9323717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-syndromic retinal ciliopathies: translating gene discovery into therapy.
    Estrada-Cuzcano A; Roepman R; Cremers FP; den Hollander AI; Mans DA
    Hum Mol Genet; 2012 Oct; 21(R1):R111-24. PubMed ID: 22843501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention and therapy in hereditary retinal degenerations.
    Besch D; Zrenner E
    Doc Ophthalmol; 2003 Jan; 106(1):31-5. PubMed ID: 12675483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene Therapy for MERTK-Associated Retinal Degenerations.
    LaVail MM; Yasumura D; Matthes MT; Yang H; Hauswirth WW; Deng WT; Vollrath D
    Adv Exp Med Biol; 2016; 854():487-93. PubMed ID: 26427450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
    Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular genetics of Leber congenital amaurosis.
    Cremers FP; van den Hurk JA; den Hollander AI
    Hum Mol Genet; 2002 May; 11(10):1169-76. PubMed ID: 12015276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toward an elucidation of the molecular genetics of inherited retinal degenerations.
    Farrar GJ; Carrigan M; Dockery A; Millington-Ward S; Palfi A; Chadderton N; Humphries M; Kiang AS; Kenna PF; Humphries P
    Hum Mol Genet; 2017 Aug; 26(R1):R2-R11. PubMed ID: 28510639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Is Next for Retinal Gene Therapy?
    Vandenberghe LH
    Cold Spring Harb Perspect Med; 2015 Apr; 5(10):. PubMed ID: 25877395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developing an Outcome Measure With High Luminance for Optogenetics Treatment of Severe Retinal Degenerations and for Gene Therapy of Cone Diseases.
    Cideciyan AV; Roman AJ; Jacobson SG; Yan B; Pascolini M; Charng J; Pajaro S; Nirenberg S
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3211-21. PubMed ID: 27309625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stem cells as tools for studying the genetics of inherited retinal degenerations.
    Wiley LA; Burnight ER; Mullins RF; Stone EM; Tucker BA
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a017160. PubMed ID: 25502747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biology and therapy of inherited retinal degenerative disease: insights from mouse models.
    Veleri S; Lazar CH; Chang B; Sieving PA; Banin E; Swaroop A
    Dis Model Mech; 2015 Feb; 8(2):109-29. PubMed ID: 25650393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse.
    Reichel MB; Bainbridge J; Baker D; Thrasher AJ; Bhattacharya SS; Ali RR
    Br J Ophthalmol; 2001 Mar; 85(3):341-4. PubMed ID: 11222343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the molecular understanding of canine retinal diseases.
    Petersen-Jones S
    J Small Anim Pract; 2005 Aug; 46(8):371-80. PubMed ID: 16119056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.